„Ginza“
Suchergebnisse
1.000+ Treffer
-
TOP10 Reiseführer Tokyo – TOP10-Listen zu Highlights, Themen und Stadtteilen. Ideal für unterwegs. Mit wetterfester Extra-Karte. Von Reisenden. Für Reisende.
-
Lexidion et Onomasticon Codicis Nasaraei, cui Liber Adami Nomen – Mandaic-Latin Lexicon and Onomasticon to the Ginza (Liber Adami)
-
Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
-
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients
-
HIZA GINZA – = 膝銀座 = ヒザギンザ
-
Ginza
-
Anatomical and metabolic brain imaging correlation of neurological improvements following hyperbaric oxygen therapy—post-stroke recovery: a case report
-
Ginza Rhapsody – EPCOTIA LIVE Version = 銀座ラプソディ : EPCOTIA LIVE Ver. = ギンザラプソディ : エプコティアライブバージョン
-
Efficacy of hyperbaric oxygen therapy in treating fibromyalgia linked to childhood trauma after late-onset and over a decade of symptoms: a case report
-
Enhancing the Interpretation of Industrial Heritage and Cultural Landscape of Iwami Ginzan through Digital Technologies
-
Leveraging social media for resilient cultural heritage: a people-centred conceptual framework for community engagement and crisis response
-
Soba-Nudeln rühren mich zu Tränen – eine kulinarische Reise in Japan : mit zehn Kochrezepten
-
Paula Scher – = Pōra Shea
-
Ginzā – Der Schatz oder Das große Buch der Mandäer
-
Exploring the concept of Total Pain in contemporary oncology palliative care: a qualitative study on patients' resources
-
Adaptive Hybrid Energy System (AHES) for smart home: Lebanese case/application
-
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
-
Drache und Adler – Streifzüge durch Ginza und Wall Street
-
Über das Vorkommen von Adenin in den Bambusschößlingen.
-
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial